DurvalumabAnti-TIF1γ antibody-positive dermatomyositis: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2021年 / 1876卷 / 1期
关键词：
D O I：
10.1007/s40278-021-03381-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：132 / 132
相关论文
共 50 条
  • [1] Anti-TIF1-γ antibody-positive dermatomyositis
    Li, Chia-Lun
    Ma, Sheng-Hsiang
    Wu, Chen-Yi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (12) : 2583 - 2584
  • [2] Transcriptional intermediary factor 1 (TIF1) and anti-TIF1γ antibody-positive dermatomyositis
    Kotobuki, Yorihisa
    Tonomura, Kyoko
    Fujimoto, Manabu
    IMMUNOLOGICAL MEDICINE, 2021, 44 (01) : 23 - 29
  • [3] Clinicopathological characteristics of anti-TIF1-gamma antibody-positive dermatomyositis
    Yamanaka, A.
    Eura, N.
    Yamaoka, M.
    Ozaki, M.
    Shiota, T.
    Nanaura, H.
    Sugie, K.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S51 - S51
  • [4] Amyopathic anti-TIF1-γ antibody-positive dermatomyositis in a young man
    Kluger, Nicolas
    JEADV CLINICAL PRACTICE, 2024, 3 (03): : 891 - 894
  • [5] Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy
    Harada, Yumi
    Tominaga, Masaki
    Iitoh, Eriko
    Kaieda, Shinjiro
    Koga, Takuma
    Fujimoto, Kiminori
    Chikasue, Tomonori
    Obara, Hitoshi
    Kakuma, Tatsuyuki
    Ida, Hiroaki
    Kawayama, Tomotaka
    Hoshino, Tomoaki
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [6] Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
    Nakanishi, Yu
    Yamaguchi, Kakuhiro
    Yoshida, Yusuke
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Masuda, Takeshi
    Nakashima, Taku
    Miyamoto, Shintarou
    Iwamoto, Hiroshi
    Hirata, Shintaro
    Fujitaka, Kazunori
    Hamada, Hironobu
    Sugiyama, Eiji
    Hattori, Noboru
    INTERNAL MEDICINE, 2020, 59 (20) : 2553 - 2558
  • [7] Anti-TIF1-γ antibody-positive dermatomyositis caused by camrelizumab in a patient with oesophageal cancer
    Li, J.
    Yi, S.
    Huang, Y.
    Peng, Y.
    Yang, Z.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 395 - 395
  • [8] NivolumabAnti-transcriptional intermediary factor 1γ antibody-positive dermatomyositis: case report
    Reactions Weekly, 2023, 1972 (1) : 279 - 279
  • [9] Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment
    Lerman, Irina
    Richardson, Christopher T.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (09)
  • [10] PembrolizumabAnti-TIF1-γ(Ab) positive dermatomyositis: case report
    Reactions Weekly, 2022, 1926 (1) : 385 - 385
12345